Evidence map›Paper›PMID 32355262›Full record

ArticleScientific reports2020

Replication analysis of variants associated with multiple sclerosis risk.

Mohammad Dashti, Khadijah Ateyah, Raed Alroughani, Rabeah Al-Temaimi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mohammad DashtiGenetics and Bioinformatics department, Dasman Diabetes Institute, Sharq, Kuwait City, Kuwait.
Khadijah AteyahUndergraduate medical program, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
Raed AlroughaniNeurology Clinic, Amiri Hospital, Kuwait City, Kuwait.
Rabeah Al-TemaimiHuman Genetics Unit, Department of Pathology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait. rabeah@hsc.edu.kw.
Kuwait University · KWAmiri Hospital · KWDasman Diabetes Institute · KW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple Sclerosis (MS) is a complex chronic neurodegenerative disorder resulting from an autoimmune reaction against myelin. So far, many genetic variants have been reported to associate with MS risk however their association is inconsistent across different populations. Here we investigated the association of the most consistently reported genetic MS risk variants in the Kuwaiti MS population in a case-control study designs. Of the 94 reported MS risk variants four variants showed MS risk association in Arabs exome analysis (EVI5 rs11808092 p = 0.0002; TNFRSF1A rs1800693 p = 0.00003; MTHFR rs1801131 p = 0.038; and CD58 rs1414273 p = 0.00007). Replication analysis in Kuwaiti MS cases and healthy controls confirmed EVI5 rs11808092A (OR: 1.6, 95%CI: 1.19-2.16, p = 0.002) and MTHFR rs1801131G (OR: 1.79, 95%CI: 1.3-2.36, p = 0.001) as MS risk genetic factors, while TNFRSF1A rs1800693C had a marginal MS risk association (OR: 1.36, 95%CI: 1.04-1.78, p = 0.025) in the Kuwaiti population. CD58 rs1414273 did not sustain risk association (p = 0.37). In conclusion, EVI5 rs11808092A, TNFRSF1A rs1800693C and MTHFR rs1801131G are MS risk factors in the Kuwaiti population. Further investigations into their roles in MS pathogenesis and progression are merited.

Indexed as

Genetic VariationPolymorphism, Single NucleotideAdultAllelesCase-Control StudiesCD58 AntigensCell Cycle ProteinsExomeFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeGTPase-Activating ProteinsHumansKuwaitMaleCD58 AntigensCell Cycle ProteinsEVI5 protein, humanGTPase-Activating ProteinsMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, humanReceptors, Tumor Necrosis Factor, Type ITNFRSF1A protein, human

Identifiers

PMID32355262
PMCPMC7193640
OpenAlexW3022214100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.